Topics
Glioblastoma | Prognosis | Therapy timing
Home > Publications > Topics > Glioblastoma > Prognosis > Therapy timing
Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D,
Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen
TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo
EO, Brandal P.
The impact of cancer
patient pathway on timing of radiotherapy and survival: a cohort
study in glioblastoma patients.
J
Neurooncol. 2024 May 19. doi:
10.1007/s11060-024-04709-z. PMID:
38762830. Observational study. ˍ
Leppert J, Ditz C, Grohmann M, Ziemann C, Hillbricht C, Liubich L,
Matone MV, Rades D, Gliemroth J, Löser A.
Therapy
Intensity Outweighs the Prognostic
Importance of the Timing of
Chemoradiotherapy in Newly Diagnosed Glioblastoma
Patients.
Anticancer
Res. 2024 Oct;44(10):4403-4412. doi:
10.21873/anticanres.17269. PMID:
39348995. Observational study. ˍ